{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:44:57Z","timestamp":1794257097978,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Association Force H\u00e9mato"},{"name":"French Ministry of Health and the French National Cancer Institute","award":["PRT-K2017-109"],"award-info":[{"award-number":["PRT-K2017-109"]}]},{"name":"French Ministry of Health and the French National Cancer Institute","award":["PRT-K2017-109"],"award-info":[{"award-number":["PRT-K2017-109"]}]},{"name":"French Ministry of Health and the French National Cancer Institute","award":["PRT-K2017-109"],"award-info":[{"award-number":["PRT-K2017-109"]}]},{"name":"IHU THEMA"},{"name":"ITMO Cancer of Aviesan"},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile-de-France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007394","name":"Association Laurette Fugain","doi-asserted-by":"publisher","award":["ALF 2016-07"],"award-info":[{"award-number":["ALF 2016-07"]}],"id":[{"id":"10.13039\/100007394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07717-9","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:45:15Z","timestamp":1751467515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system"],"prefix":"10.1038","volume":"15","author":[{"given":"B\u00e9r\u00e9nice","family":"Schell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Pierre","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"M\u2019Sibih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kalogeraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Kergaravat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Lereclus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Esp\u00e9li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Balabanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dulphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"7717_CR1","doi-asserted-by":"publisher","first-page":"1195194","DOI":"10.3389\/fimmu.2023.1195194","volume":"14","author":"Y Lang","year":"2023","unstructured":"Lang, Y., Lyu, Y., Tan, Y. & Hu, Z. Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy. Front. Immunol. 14, 1195194 (2023).","journal-title":"Front. Immunol."},{"key":"7717_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exphem.2020.11.008","volume":"94","author":"P Sommerkamp","year":"2021","unstructured":"Sommerkamp, P., Mercier, F. E., Wilkinson, A. C., Bonnet, D. & Bourgine, P. E. Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation. Exp. Hematol. 94, 20\u201325 (2021).","journal-title":"Exp. Hematol."},{"key":"7717_CR3","doi-asserted-by":"crossref","unstructured":"Pievani, A. et al. Harnessing mesenchymal stromal cells for the engineering of human hematopoietic niches. Front. Immunol. 12\u00a0(2021).","DOI":"10.3389\/fimmu.2021.631279"},{"key":"7717_CR4","doi-asserted-by":"crossref","unstructured":"Unnikrishnan, K., Thomas, L. V. & Ram Kumar, R. M. Advancement of Scaffold-Based 3D cellular models in Cancer tissue engineering: an update. Front. Oncol. 11\u00a0(2021).","DOI":"10.3389\/fonc.2021.733652"},{"key":"7717_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.4049\/jimmunol.2200836","volume":"210","author":"A de Janon","year":"2023","unstructured":"de Janon, A., Mantalaris, A. & Panoskaltsis, N. Three-Dimensional human bone marrow organoids for the study and application of normal and abnormal hematoimmunopoiesis. J. Immunol. 210, 895\u2013904 (2023).","journal-title":"J. Immunol."},{"key":"7717_CR6","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","volume":"125","author":"CJ Eaves","year":"2015","unstructured":"Eaves, C. J. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125, 2605\u20132613 (2015).","journal-title":"Blood"},{"key":"7717_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1182\/blood-2014-10-570234","volume":"125","author":"LT Vo","year":"2015","unstructured":"Vo, L. T. & Daley, G. Q. De Novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125, 2641\u20132648 (2015).","journal-title":"Blood"},{"key":"7717_CR8","doi-asserted-by":"crossref","unstructured":"De Kleer, I., Willems, F., Lambrecht, B. & Goriely, S. Ontogeny of myeloid cells. Front. Immunol. 5\u00a0(2014).","DOI":"10.3389\/fimmu.2014.00423"},{"key":"7717_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri2024","volume":"7","author":"F Rosenbauer","year":"2007","unstructured":"Rosenbauer, F. & Tenen, D. G. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 7, 105\u2013117 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"7717_CR10","doi-asserted-by":"crossref","unstructured":"Fine, N., Tasevski, N., McCulloch, C. A., Tenenbaum, H. C. & Glogauer, M. The neutrophil: constant defender and first responder. Front. Immunol. 11\u00a0(2020).","DOI":"10.3389\/fimmu.2020.571085"},{"key":"7717_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/35030112","volume":"407","author":"M Kondo","year":"2000","unstructured":"Kondo, M. et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407, 383\u2013386 (2000).","journal-title":"Nature"},{"key":"7717_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-immunol-101921-044122","volume":"41","author":"O Kyrysyuk","year":"2023","unstructured":"Kyrysyuk, O. & Wucherpfennig, K. W. Designing Cancer immunotherapies that engage T cells and NK cells. Annu. Rev. Immunol. 41, 17\u201338 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"7717_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier, E. et al. Natural killer cell therapies. Nature 626, 727\u2013736 (2024).","journal-title":"Nature"},{"key":"7717_CR14","doi-asserted-by":"publisher","first-page":"e20231222","DOI":"10.1084\/jem.20231222","volume":"221","author":"LL Lanier","year":"2024","unstructured":"Lanier, L. L. Five decades of natural killer cell discovery. J. Exp. Med. 221, e20231222 (2024).","journal-title":"J. Exp. Med."},{"key":"7717_CR15","doi-asserted-by":"crossref","unstructured":"Granzin, M. et al. Shaping of natural killer cell antitumor activity by ex vivo cultivation. Front. Immunol. 8\u00a0(2017).","DOI":"10.3389\/fimmu.2017.00458"},{"key":"7717_CR16","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1089\/scd.2014.0597","volume":"24","author":"MWH Roeven","year":"2015","unstructured":"Roeven, M. W. H. et al. The Aryl hydrocarbon receptor antagonist stemRegenin1 improves in vitro generation of highly functional natural killer cells from CD34\u2009+\u2009Hematopoietic stem and progenitor cells. Stem Cells Dev. 24, 2886\u20132898 (2015).","journal-title":"Stem Cells Dev."},{"key":"7717_CR17","doi-asserted-by":"publisher","first-page":"e1017701","DOI":"10.1080\/2162402X.2015.1017701","volume":"4","author":"J Cany","year":"2015","unstructured":"Cany, J. et al. Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer. OncoImmunology 4, e1017701 (2015).","journal-title":"OncoImmunology"},{"key":"7717_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet, C. S. et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods. 14, 521\u2013530 (2017).","journal-title":"Nat. Methods"},{"key":"7717_CR19","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.biomaterials.2009.11.094","volume":"31","author":"TM Blanco","year":"2010","unstructured":"Blanco, T. M., Mantalaris, A., Bismarck, A. & Panoskaltsis, N. The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. Biomaterials 31, 2243\u20132251 (2010).","journal-title":"Biomaterials"},{"key":"7717_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2141.1994.tb05104.x","volume":"88","author":"M Syrj\u00e4l\u00e4","year":"1994","unstructured":"Syrj\u00e4l\u00e4, M., Ruutu, T. & Jansson, S. E. A flow cytometric assay of CD34-positive cell populations in the bone marrow. Br. J. Haematol. 88, 679\u2013684 (1994).","journal-title":"Br. J. Haematol."},{"key":"7717_CR21","doi-asserted-by":"crossref","unstructured":"Di Vito, C., Mikulak, J. & Mavilio, D. On the way to become a natural killer cell. Front. Immunol. 10\u00a0(2019).","DOI":"10.3389\/fimmu.2019.01812"},{"key":"7717_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jphotobiol.2017.03.024","volume":"170","author":"S Shah","year":"2017","unstructured":"Shah, S. et al. Fluorescence properties of doxorubicin in PBS buffer and PVA films. J. Photochem. Photobiol B. 170, 65\u201369 (2017).","journal-title":"J. Photochem. Photobiol B"},{"key":"7717_CR23","doi-asserted-by":"publisher","first-page":"34178","DOI":"10.18632\/oncotarget.6213","volume":"6","author":"E Sohlberg","year":"2015","unstructured":"Sohlberg, E. et al. Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome. Oncotarget 6, 34178\u201334190 (2015).","journal-title":"Oncotarget"},{"key":"7717_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41467-023-36193-w","volume":"14","author":"M Boy","year":"2023","unstructured":"Boy, M. et al. Myelodysplastic syndrome associated TET2 mutations affect NK cell function and genome methylation. Nat. Commun. 14, 588 (2023).","journal-title":"Nat. Commun."},{"key":"7717_CR25","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2014-09-570192","volume":"125","author":"PE Boulais","year":"2015","unstructured":"Boulais, P. E. & Frenette, P. S. Making sense of hematopoietic stem cell niches. Blood 125, 2621\u20132629 (2015).","journal-title":"Blood"},{"key":"7717_CR26","doi-asserted-by":"publisher","first-page":"e10516","DOI":"10.1002\/jbm4.10516","volume":"5","author":"CA Soto","year":"2021","unstructured":"Soto, C. A., Celso, L., Purton, C., Frisch, B. J. & L. E. & From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment. JBMR Plus. 5, e10516 (2021).","journal-title":"JBMR Plus"},{"key":"7717_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/2643-3230.BCD-23-0202","volume":"5","author":"C Restelli","year":"2024","unstructured":"Restelli, C. et al. Recent advances in Immune-Based therapies for acute myeloid leukemia. Blood Cancer Discov. 5, 234\u2013248 (2024).","journal-title":"Blood Cancer Discov"},{"key":"7717_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-023-03381-w","volume":"14","author":"M Peshkova","year":"2023","unstructured":"Peshkova, M. et al. MSCs\u2019 conditioned media cytokine and growth factor profiles and their impact on macrophage polarization. Stem Cell. Res. Ther. 14, 142 (2023).","journal-title":"Stem Cell. Res. Ther."},{"key":"7717_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/blood-2023-191081","volume":"142","author":"J Ropa","year":"2023","unstructured":"Ropa, J. et al. Local oxygen dictates hematopoietic cell growth and function. Blood 142, 1307 (2023).","journal-title":"Blood"},{"key":"7717_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3324\/haematol.2011.050815","volume":"97","author":"D Jing","year":"2012","unstructured":"Jing, D. et al. Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro. Haematologica 97, 331\u2013339 (2012).","journal-title":"Haematologica"},{"key":"7717_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00262-017-2014-y","volume":"66","author":"S Sangaletti","year":"2017","unstructured":"Sangaletti, S., Chiodoni, C., Tripodo, C. & Colombo, M. P. Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments. Cancer Immunol. Immunother CII. 66, 1059\u20131067 (2017).","journal-title":"Cancer Immunol. Immunother CII"},{"key":"7717_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","volume":"30","author":"B Amulic","year":"2012","unstructured":"Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D. & Zychlinsky, A. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459\u2013489 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"7717_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12915-022-01264-9","volume":"20","author":"C Dussiau","year":"2022","unstructured":"Dussiau, C. et al. Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level. BMC Biol. 20, 60 (2022).","journal-title":"BMC Biol."},{"key":"7717_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/asheducation-2017.1.73","volume":"2017","author":"SS Chung","year":"2017","unstructured":"Chung, S. S. & Park, C. Y. Aging, hematopoiesis, and the myelodysplastic syndromes. Hematol. Am. Soc. Hematol. Educ. Program. 2017, 73\u201378 (2017).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"7717_CR35","doi-asserted-by":"publisher","first-page":"106156","DOI":"10.1016\/j.nbd.2023.106156","volume":"183","author":"C Qi","year":"2023","unstructured":"Qi, C. & Liu, Q. Natural killer cells in aging and age-related diseases. Neurobiol. Dis. 183, 106156 (2023).","journal-title":"Neurobiol. Dis."},{"key":"7717_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/cas.16066","volume":"115","author":"M Sakurai","year":"2024","unstructured":"Sakurai, M., Ishitsuka, K., Becker, H. J. & Yamazaki, S. Ex vivo expansion of human hematopoietic stem cells and clinical applications. Cancer Sci. 115, 698\u2013705 (2024).","journal-title":"Cancer Sci."},{"key":"7717_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","volume":"16","author":"AG Freud","year":"2016","unstructured":"Freud, A. G. et al. NKp80 defines a critical step during human natural killer cell development. Cell. Rep. 16, 379\u2013391 (2016).","journal-title":"Cell. Rep."},{"key":"7717_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","volume":"22","author":"AG Freud","year":"2005","unstructured":"Freud, A. G. et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22, 295\u2013304 (2005).","journal-title":"Immunity"},{"key":"7717_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-1425-9_1","volume":"2308","author":"V Bisio","year":"2021","unstructured":"Bisio, V., Esp\u00e9li, M., Balabanian, K., Anginot, A. & Culture Expansion and differentiation of human bone marrow stromal cells. Methods Mol. Biol. Clifton NJ. 2308, 3\u201320 (2021).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"7717_CR40","doi-asserted-by":"crossref","unstructured":"Lorenzo-Herrero, S., Sordo-Bahamonde, C., Gonz\u00e1lez, S. & L\u00f3pez-Soto, A. Chapter Twenty-Six - Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay. in Methods in Enzymology (eds Galluzzi, L. & Rudqvist) N.-P.) vol. 631 483\u2013495 (Academic, (2020).","DOI":"10.1016\/bs.mie.2019.05.036"},{"key":"7717_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fimmu.2016.00413","volume":"7","author":"YS Rocca","year":"2016","unstructured":"Rocca, Y. S. et al. Phenotypic and functional dysregulated blood NK cells in colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15. Front. Immunol. 7, 413 (2016).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07717-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:45:21Z","timestamp":1751467521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7717"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07717-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B\u00e9r\u00e9nice SCHELL, Lin-Pierre ZHAO, Antoine TOUBERT, Marion ESPELI, Karl BALABANIAN, Nicolas DULPHY, Valeria BISIO and the French National Institute of Health and Medical Research (INSERM) declare pending patent application (#EP23306658.8) relating to the AMO system. All other authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23603"}}